CathLab Digest

Digital Edition

DIGITAL EDITION

Interactive BONUS content delivered to your email

CLICK HERE TO CONTINUE »

CLINICAL EVENTS CALENDAR

  • Start
    Oct 22,2008
    End
    Oct 23,2008
    The Joint Commission Presents Laboratories: Accreditation Essentials (Beginner: 10/22; Advanced 10/23)
    www.cathlabdigest.com
  • Start
    Oct 23,2008
    End
    Oct 23,2008
    Introduction To Cardiovascular Cath Lab
    www.socalmeded.com
  • Start
    Oct 25,2008
    End
    Oct 25,2008
    Cath Lab Basics ‘08 with Dr. Morton Kern and Dr. Michael Lim
    www.cathlabdigest.com/basics2008/
  • Start
    Oct 30,2008
    End
    Oct 30,2008
    Introduction To Cardiovascular Cath Lab
    www.socalmeded.com

Non-Accredited Education

CLINICAL EXPERIENCE WITH A NEW HYBRID CORONARY WIRE
On Demand Web Archive
Non-Accredited
Target Audience: Physicians, nurses, and technologists.
This activity is supported by an educational grant from Terumo Medical Corporation.

STEMI Interventions: Commentary

Sameer Mehta, MD, FACC, MBA
VOLUME: 16 PUBLICATION DATE: Mar 01 2008
Issue Number: 
3
author: 

Sameer Mehta, MD, FACC, MBA

This month’s review of the recently published work from Ottawa, Canada, entitled “A Citywide Protocol for Primary PCI in ST-segment Elevation Myocardial Elevation” (NEJM, 2008; 358:231–240, see article abstract on next page), provides an opportunity to reflect upon numerous critical aspects that are related to the effective triage and management of patients with STEMI.
The Ottawa study is the latest in the series of notable works that the NEJM has published in the last several months on the critical subject of primary PCI and regarding the dramatic global changes that are occurring in the these patients.
To begin with, I want to congratulate the researchers at the University of Ottawa Heart Institute for their pioneering work. It is unambiguous how significantly this work will impact on the design of global STEMI care in large metropolitan areas. This reviewer is already involved in designing similar initiatives in several Asian cities for the effective triage and treatment of STEMI patients and the relevance of the Ottawa experience is transparent. This notable work supplements the work of several large projects from Europe and from the United States. Most notably, relevant comparisons to the Ottawa study can be made with the tremendous work that has been done at the Mayo Clinic and at the Abbott Northwestern Heart Center in Minneapolis.
The Ottawa protocol is unique in several aspects: 1) It is the largest published work in STEMI interventions involving systematic primary PCI for 800,000 people living in the Ottawa metropolitan area where no patient was treated with fibrinolysis alone. Notably, this care required a redesign of the traditional care of these patients, the development of new protocols for ambulance transport, changes in physician-referral patterns, and changes in emergency department (ED) protocols. This strategy is markedly different that the pharmaco-invasive, “hub and spoke” models that are practiced at the Mayo Clinic and at the Abbott Northwestern Minneapolis, and at numerous other superb U.S. programs. It is also very different than the thrust for the very early, prehospital pure fibrinolysis or facilitated fibrinolysis strategies that are advocated by a few premier European sites. Although the role of thrombolytic therapy in the era of primary PCI continues to evolve, the Ottawa study makes a further dent in the utility of this approach.
2) The work has made further inroads into the establishment of the Advanced Care Paramedics that were trained in cardiac life support and who routinely performed and interpreted 12-lead EKG at the scene, and independently performed the triage and transfer of STEMI patients to the designated center for primary PCI.
3) It has quantified with a large cohort of patients the benefits of a strategy in which paramedics independently referred patients to a designated primary PCI center and bypassed the obligatory logistical delays of presentation of the STEMI patient at an ED. Recognizing the door-to-balloon (D2B) times as the best correlate for STEMI mortality, the Ottawa protocol demonstrated a D2B time <90 minutes in 79.7% of patients that were transferred from the field and a D2B time <90 minutes in 11.9% of those transferred from the ED (p < 0.001) — these results are indisputable testimony to the overwhelming benefits of a strategy of direct transfer to the primary PCI institution! The publication of the Ottawa protocol for primary PCI also provides an opportunity to reflect upon the status of STEMI care in the United States and benefit from some of the observations from this study. In the United States, the median time to the closest PCI hospital is 11.4 minutes, and the median distance is 8.0 miles, with nearly 80% of the adult population living within 60 minutes of activation of the EMS to arrival at the PCI center. This compares with 10 minutes of traveling distance in Ottawa and 55-65% of patients that live within 30 minutes of a PCI center in Ontario. Clearly, the United States has longer transfer distances, yet there are large opportunities to improve the transfer process and decrease the time to treatment. Although data from the National Registry of Myocardial Infarction is a few years old (it is widely expected that these results have considerably improved since), it revealed that the median D2B time in 4,278 patients undergoing interhospital transfer for primary PCI was 180 minutes, with only 4% of patients having a D2B time <90 minutes and 15% <120 minutes! Three other related subjects deserve mention beyond the clear benefits of a direct transfer strategy for STEMI interventions: a) Education of the patient is paramount for STEMI care and the message is unambiguous — urgency in seeking care reduces time to treatment, and calling 911 as opposed to self-transport, is critical; b) Legislation may be required to override the financial and political constraints that prevent patients from reaching a primary PCI center directly and bypassing the community hospital that has numerous benefits in acquiring this patient; c) A national STEMI policy akin to the national trauma system is needed.
 

Your rating: None Average: 5 (1 vote)

All Subscriptions are FREE to qualified cardiology professionals

#

  • Subscribe to:
  • Journal
  • Digital Journal
  • E-News
  • RSS feed

CLICK HERE TO CONTINUE »

CME Showcase

Diagnosing Coronary Artery Disease: Advanced Cardiovascular Imaging Solutions

Complimentary accredited web archive
This activity is intended for physicians, nurses, and technologists.

Treatment Options for the AF Patient
Complimentary Accredited Dinner Symposium
This activity has been developed for physicians, nurses, and technologists who treat patients with arrythmias.


A-fib Ablation:
Practical Solutions
for the Real World

Complimentary Accredited Lunch Symposium
This activity has been developed for physicians, nurses, and technologists who treat patients with atrial fibrillation.




New Standards of Care for CRMD Antibiotic Protection

Complimentary CME Accredited Webcast

Dates:
November 18, 2008
Time: 6:00 pm ET
November 19, 2008
Time: 3:00 pm ET

This activity is sponsored by the North American Center for Continuing Medical Education.

LUMEN 2009 - THE SYMPOSIUM ON OPTIMAL TREATMENTS FOR ACUTE MI

Live Symposium

Date: February 26-28
Location: Loews Miami Beach Hotel
Miami Beach, Florida 33139

This activity is sponsored by the North American Center for Continuing Medical Education.

Hemostasis Management in Today’s Cath Lab

Complimentary Accredited Web Archive

Release Date: June 19, 2008
Expiration Date: June 19, 2009
Target Audience: This activity has been developed for physicians, nurses, and technologists.
This activity is supported by an educational grant from Radi Medical Systems, Inc.

REVIEW OUR OTHER
CARDIOLOGY BRANDS

Check out our other resources for healthcare professionals of all specialties.

  • EP Lab Digest
  • Invasive Cardiology
  • Vascular Disease Management
  • Cath Lab Basics